Gastrulation is a fundamental process during embryogenesis that shapes proper body architecture and establishes three germ layers through coordinated cellular actions of proliferation, fate specification, and movement. Although many molecular pathways involved in the specification of cell fate and polarity during vertebrate gastrulation have been identified, little is known of the signaling that imparts cell motility. Here we show that prostaglandin E 2 (PGE 2 ) production by microsomal PGE 2 synthase (Ptges) is essential for gastrulation movements in zebrafish. Furthermore, PGE 2 signaling regulates morphogenetic movements of convergence and extension as well as epiboly through the G-protein-coupled PGE 2 receptor (EP4) via phosphatidylinositol 3-kinase (PI3K)/Akt. EP4 signaling is not required for proper cell shape or persistence of migration, but rather it promotes optimal cell migration speed during gastrulation. This work demonstrates a critical requirement of PGE 2 signaling in promoting cell motility through the COX-1-Ptges-EP4 pathway, a previously unrecognized role for this biologically active lipid in early animal development.
In mammals, prostaglandins (PG) have been implicated in a myriad of physiologic and pathologic processes, ranging from fundamental body functions such as reproduction to disease progression of inflammatory-mediated diseases like rheumatoid arthritis and cancer (Langenbach et al. 1999; Narumiya et al. 1999; Gupta and DuBois 2001) . Prostaglandins are oxygenated metabolites of the 20-carbon polyunsaturated fatty acid molecule arachidonic acid, which is released from membrane phospholipids by the action of phospholipases. Cyclooxygenases (prostaglandin endoperoxide synthases, COX-1 and COX-2) catalyze the initial step in the prostaglandin biosynthesis, the conversion of arachidonic acid into PGH 2 (Smith et al. 1996) . Although COX-1 and COX-2 share similar structural and biochemical properties, they are encoded on separate chromosomes and exhibit distinct physiologic functions. Traditionally, COX-1 was thought to serve a homeostatic function, required for tissues to maintain a basal level of prostaglandins, and COX-2, the "inducible" isoform, is up-regulated by diverse stimuli including cytokines, mitogens, growth factors, and tumor promoters (Smith et al. 2000) .
PGH 2 is subsequently converted to one of several structurally related prostaglandins, PGE 2 (prostaglandin E 2 ), PGD 2␣ , PGF 2 , PGI 2 (prostaglandin I 2 ), and thromboxane A 2 (TxA 2 ), by the activity of specific PG synthases (Negishi et al. 1995) . In one such reaction, PGH 2 is converted to PGE 2 by microsomal prostaglandin E 2 synthase (Ptges), a member of the MAPEG (membraneassociated proteins in eicosanoid and glutathione metabolism) family. PGE 2 is then released from the cell and signals via binding to G-protein-coupled prostaglandin E 2 receptors (EP1-4) embedded in the plasma membrane (Negishi et al. 1995) . A large body of evidence implicates PGE 2 as a lipid messenger that regulates a wide variety of important body functions in mammals, including pain and fever, maintenance of vascular tone, and cancer progression (Kobayashi and Narumiya 2002 ). However, deciphering the role of PGE 2 in early mammalian development has been limited by the maternal contribution of prostaglandins in utero (Reese et al. 2000 (Reese et al. , 2001 . As a result, the functional role for prostaglandins in early development remains virtually unknown.
Given these limitations in mammals, zebrafish is an emerging model for understanding the functional roles for prostaglandin signaling due to their extraembryonic development (Cha et al. 2005b) . Previous studies in zebrafish demonstrated that the injection of antisense morpholino (MO) oligonucleotides designed to block the translation of cox1 transcripts leads to early gastrulation arrest, which is suppressed by coinjection of synthetic cox1 RNA (Grosser et al. 2002; Cha et al. 2005a ). The gastrulation arrest phenotype was also recapitulated following treatment with pharmacologic inhibitors of cyclooxygenase, such as indomethacin or sulindac sulfide (Cha et al. 2005a ). These observations prompted us to explore the specific prostaglandin signaling downstream of COX-1 during the early developmental process of gastrulation (Stern 2004) .
Results
To understand the downstream effectors of COX-1 signaling during gastrulation, we initially analyzed the highly conserved zebrafish ortholog of PGE 2 synthase, Ptges (Pini et al. 2005) . The analysis of spatiotemporal expression revealed that ptges transcripts are maternally deposited and ubiquitously distributed during gastrulation, revealing that ptges and cox1 transcripts colocalize during gastrulation (Fig. 1A,C) . On the other hand, cox2 transcripts are not detected until after the end of gastrulation specifically in the anterior neuroectoderm (Fig.  1B) . Analogous to other systems, these findings suggested that the zebrafish Ptges functions downstream of COX-1 during gastrulation to generate PGE 2 . Accordingly measurements of prostaglandin levels using mass spectrometry revealed the production of PGE 2 during gastrulation, along with PGF 2␣ (prostaglandin F 2␣ ) and PGI 2 (Cha et al. 2005a) , which parallels studies demonstrating the presence of PGE 2 and PGF 2␣ in developing mammalian blastocysts (Davis et al. 1983) .
To address the function of PGE 2 signaling during zebrafish gastrulation, we designed two MOs to target ptges transcripts: One, ptges-MO1, is complementary to the 5Ј-untranslated region (UTR) and is expected to block translation, and the second, ptges-MO2, is complementary to the first intron-exon boundary and is expected to cause a splicing defect. Following ptges-MO1 or MO2 injections, we observed severe morphogenetic defects during gastrulation at a dose of 2 ng. Ptges-deficient embryos displayed a mispositioned head and shortened anteroposterior (AP) axis with delayed epiboly that completed only at tailbud or segmentation stage (Fig.  2B ). After injection of a 4-ng dose of ptges-MO2, the embryos underwent complete gastrulation arrest similar to what we observed in COX-1-deficient embryos (Fig.  2C,E) . To further characterize the morphological abnormalities associated with the loss of Ptges function, we analyzed the expression of several cell-type-specific markers at late gastrulation, anterior neuroectoderm (six3b) (Seo et al. 1999) , mid-hindbrain boundary (pax2.1) (Krauss et al. 1991a) , and axial and prospective posterior mesoderm (no tail/brachyury) (Schulte-Merker et al. 1994) . While the transcripts of these markers were detected in Ptges-deficient embryos, their expression domains were shortened anteroposteriorly and widened mediolaterally (Fig. 2J,M) . In addition, no tail expression in the nascent mesoderm revealed an enlarged blastopore. Marker analyses further suggested that Ptges-deficient embryos have defects in several gastrulation movements, including convergence, extension, and epiboly. Therefore, we hypothesized that Ptges-derived PGE 2 plays an essential role in regulating cell movement during gastrulation.
To address whether lack of PGE 2 production is solely responsible for these gastrulation defects, we tested whether the addition of exogenous PGE 2 , a downstream prostaglandin product of PGE 2 synthase, could rescue the gastrulation phenotype in Ptges-deficient embryos. Ptges morphants were incubated in control media or media supplemented with PGE 2 , PGF 2␣ , or PGI 2 , the predominant prostaglandins during zebrafish gastrulation. All morphants treated with PGI 2 (n = 55) (Fig. 2F) or PGF 2␣ (n = 60) (Fig. 2G ) exhibited gastrulation defects similar to untreated Ptges-deficient embryos. In contrast, 92% of morphants (n = 84) incubated in PGE 2 (Fig.  2H ) completed epiboly and survived past tailbud stage ( Supplementary Fig. 1 ), suggesting that Ptges regulates cell movement through secreted PGE 2 . Furthermore, we observed that the shapes of expression domains of pax2.1, six3b, and no tail were partially restored in Ptges morphants treated with PGE 2 to those of uninjected control embryos (Fig. 2K,N,T,U) . We also found that coin- jecting mouse Ptges RNA (50 pg) suppressed the gastrulation defects in Ptges morphants in 75% of embryos (n = 120) ( Fig. 2H; Supplementary Fig. 1 ), further demonstrating the specificity of the ptges-MOs. In addition, the gastrulation arrest in embryos injected with a 4-ng dose of ptges-MO2 was also partially suppressed by PGE 2 treatment (Fig. 2P,Q) . We also tested the effectiveness of the ptges-MO. We observed that injection of 2 or 4 ng of ptges-MO2, targeting the first intron-exon boundary, results in truncation of the transcript size by ∼82 base pairs (bp) due to deletion of exon 2 (Supplementary Fig. 2A ). Since this splicing MO targets the beginning of exon 2, the splicing machinery targets the splicing donor site of intron 1 and the acceptor site of exon 3 to cause deletion of exon 2. In addition, some wild-type transcripts remain in embryos injected with 2 ng, but not in embryos injected with 4 ng of ptges-MO2, further demonstrating that injection of 2 ng of ptges-MO2 represents a hypomorphic situation (Supplementary Fig. 2A ). Interestingly, overexpression of ptges RNA did not lead to any observable gastrulation abnormalities. This is also consistent with our previous finding that incubation of wildtype embryos with high doses of PGE 2 or overexpression of COX-1 didn't cause any noticeable defects during development (Cha et al. 2005) . The remarkable ability of PGE 2 to overcome the gastrulation defect in Ptges morphants and normal gastrulation in embryos with excess PGE 2 indicate that this lipid messenger plays an essential but permissive role in gastrulation movements of convergence and extension as well as epiboly.
Next we sought to identify downstream effectors of PGE 2 during gastrulation. In mammals, EP receptors (EP1-4), members of the G-protein-coupled receptor (GPCR) family, bind to PGE 2 with high affinity to activate downstream signals (Breyer et al. 2001) . We searched the NCBI database and identified zebrafish ESTs with the highest sequence similarities to mammalian EP receptors, designated as Ep2 and Ep4 (Supplementary Fig. 3 ). Spatiotemporal analysis of ep2 and ep4 expression demonstrated ubiquitous distribution of ep4 transcripts in early embryos before the onset of the zygotic transcription and also later throughout gastrulation, while ep2 RNA was not detected until the end of gastrulation. RT-PCR analysis confirmed the presence of ptges and ep4, but not ep2, transcripts during gastrulation ( Fig. 1D ; data not shown). To address the role of Ep2 and Ep4 receptors in early embryonic development, we designed two MOs targeting ep2 and ep4 receptor transcripts (MO1 targets 5Ј-UTR, while MO2 targets the start codon), to block their translation. Embryos injected with up to 15 ng of ep2-MO1 or ep2-MO2 failed to demonstrate any effect on gastrulation, consistent with the lack of expression during early development. However, injection of 2 ng of ep4-MO1 or ep4-MO2 produced embryos with vegetally shifted heads and shortened AP axes at the end of the gastrula period (95% of embryos displayed this phenotype, n = 130) ( Fig. 3D ,E). The shortening of the AP axis was observed throughout the somitogenesis stages, and at 24 h post-fertilization (hpf), EP4-deficient embryos exhibited a shortened AP axis, laterally elongated somites, and wavy notochord (Fig.  3F ). This phenotype resembles that of mutants in the noncanonical Wnt/planar cell polarity (PCP) pathway defective in convergence and extension gastrulation movements, such as knypek (Topczewski et al. 2001) , trilobite (Jessen et al. 2002) , and pipetail (wnt5) (Rauch et al. 1997) . Next, we determined whether ptges-MO and ep4-MO demonstrate synergism. Coinjection of suboptimal dose of ep4-MO2 (1 ng) with ptges-MO2 (1 ng) produced embryos with a more severely shortened body axis at 24 hpf as compared with those embryos injected with a 1-ng dose of either ep4-MO or ptges-MO2 ( Supplementary Fig.  2C ). This result is consistent with Ptges and Ep4 functioning in the same genetic pathway.
To understand better the morphological differences in EP4-deficient embryos, we examined the expression of several cell-type-specific genes. The expression of goosecoid (gsc), a presumptive prechordal mesoendoderm marker, and bmp4, a marker of ventroposterior tissues, was similar to that in uninjected sibling embryos at the shield stage, indicating normal patterning during early gastrulation (Fig. 3K,L) . Next we found that dorsal midline expression of no tail was widened and its blastopore expression domain animally shifted (Fig. 3O) , while the expression domains of neural markers were shortened in the AP axis (Fig. 3P) , reminiscent of the convergence, extension, and epiboly defects in Ptges-deficient embryos. However, in contrast to Ptges-and COX-1-deficient embryos, and consistent with the function of EP4 downstream of PGE 2 , gastrulation defects of EP4 morphants were not suppressed by exogenously supplied PGE 2 (0%, n = 55). To test the efficiency by which ep4-MO inhibit Ep4 function, we designed an Ep4-GFP construct. We observed that coinjection of synthetic ep4-GFP RNA with ep4-MO2 resulted in a loss of GFP expression compared with embryos injected with ep4-GFP RNA alone ( Supplementary Fig. 2B ). These experiments support the argument that the ep4-MO leads to a strong Ep4 loss of function, consistent with the inability of PGE 2 to suppress gastrulation defects. Injection of synthetic ep4 RNA at 80 pg led to a mild epiboly and convergence and extension defects and ultimately resulted in a shortened tail at 24 hpf (Fig. 3G ). In addition, coinjection of this ep4 RNA with ep4-MO2 suppressed the strong convergence and extension phenotype of EP4-deficient embryos (52% of embryos had partially restored wild-type phenotype at 24 hpf; n = 72), demonstrating the specificity of the ep4-MO2. However, injection of ep4 RNA at higher levels led to a dose-dependent defect in convergence and extension (data not shown) and did not suppress the morphant phenotype in rescue experiments. Previously it has been shown that genes that regulate cell movement often have similar phenotypes in loss-of-function (LOF) or gain-of-function (GOF) experiments (Jessen et al. 2002; Carreira-Barbosa et al. 2003; Lin et al. 2005) , suggesting that the levels of these gene products must be tightly regulated. These results show that EP4 receptors, similar to Ptges, regulate cell movements without altering patterning and fate specification. In addition, EP4 specifically acts as a receptor for the Ptges-derived PGE 2 to regulate cell movement during gastrulation.
The morphological abnormalities observed in Ptgesand EP4-deficient embryos are consistent with convergence, extension, and epiboly defects. To identify cell behaviors that depend on EP4 receptor function, we performed Nomarski time-lapse analyses of lateral mesoderm cells in wild-type (two embryos, 84 cells), control ep4-MO-injected (EP4-MOc) (two embryos, 80 cells), and ep4-MO2-injected (six embryos, 224 cells) embryos at mid-gastrulation. These moderately elongated cells undergo directed migration toward the dorsal midline along complex trajectories (Jessen et al. 2002) . Analysis of total movement speed, accounting for the cell movement in all directions, showed that cells in EP4-deficient embryos had reduced total speed (75% of the control level). In addition, the net dorsal speed was also attenuated to a similar degree, which was 67% of the control level ( Fig.  4D ; Supplementary Movies 1-3) . By comparing the meandering index, a ratio of total to the net path, which measures the tendency of cells to deviate from their directional path, we found that the lateral mesodermal cells in EP4-deficient embryos largely migrate toward the dorsal midline along trajectories similar to the control cells (wild type = 1.29, n = 84; EP4-deficient embryos = 1.19, n = 224; p < 0.57) (Figs. 4E, 5) , indicating that the directional cell movement in EP4-deficient embryos is not significantly compromised. In addition, we found that the shape of cells in this population, as determined by the length-to-width ratio (LWR), remains relatively unchanged in EP4 morphants, as compared with ep4-MOc-injected or uninjected wild type (Fig. 4F) at mid-gastrulation. The normal cell shape and meandering index associated with defective convergence movements of lateral mesodermal cells in EP4-deficient embryos contrast cellular defects reported for embryos with defective G␣12/13 signaling (Lin et al. 2005) . In this situation, impaired convergence of lateral mesodermal cells has been linked to rounder cell shapes and less persistent dorsal movement. Therefore, given the above observations and impaired epiboly in COX-1-, Ptges-, and EP4-deficient embryos, these studies provide evidence that PGE 2 signaling primarily regulates motility of mesodermal cells during gastrulation, without significantly altering cell shape or persistence of migration.
We have previously shown that PGE 2 can affect cancer metastasis by increasing proliferation, migration, and invasiveness of cancer cells and the stimulatory effects of PGE 2 are dependent on the activation of the phosphatidylinositol 3-kinase (PI3K)/Akt pathway (Sheng et al. 2001; Buchanan et al. 2003) . The serine/threonine kinase Akt, or protein kinase B (Akt/PKB) is a direct downstream effector of PI3K. Akt/PKB lies at the crossroad of multiple cellular signaling pathways and acts as a transducer of inputs initiated by receptor signaling cascades that activate PI3K (Katso et al. 2001) . Embryos treated with the PI3K inhibitor LY294002 exhibited abnormal morphology consistent with defects in convergence and extension, as well as epiboly during gastrulation (Fig.  6B) , mimicking phenotypes of Ptges-and EP4-deficient embryos. To test whether PI3K/Akt activation is mediated by the EP4 receptor, we determined the phosphorylation status of Akt in embryos injected with MOs against ep2, ep4, and ptges transcripts. The zebrafish homolog of Akt has been cloned previously, and was shown to exhibit the phosphorylation sites identified in human Akt, Thr308, and Ser473 (Chan et al. 2002) . In both EP4-and Ptges-deficient embryos, we observed a significant decrease in levels of the phosphorylated form of Akt (Fig.  6D,E) , while the total Akt levels were constant. Consistent with a permissive role of PGE 2 , the embryos with high levels of PGE 2 did not result in increased phosphorylation of Akt (Fig. 6F) . We also tested the possibility that the ERK pathway, as shown previously (Fujino et al. 2003) , can mediate the EP4 signaling and found that ERK signaling is not affected in EP4-deficient embryos (Fig. 6G) , showing the restriction of EP4 signaling to the PI3K/Akt pathway. Taken together, our data suggest that the EP4 receptor acts upstream of the PI3K/Akt pathway to regulate cell movement during gastrulation (Fig. 6H) .
Discussion
Previous studies in mice have not revealed much about the role for prostaglandins in early development. In heterozygous matings, Cox-1-null mice were born in the expected ratios and lived a normal life span (Langenbach et al. 1995) . This finding was quite surprising given the putative "housekeeping" function of the COX-1 enzyme. Although Cox-2-null mice demonstrated numerous developmental defects (Dinchuk et al. 1995) , their embryogenesis proceeded normally. Given the vital role of prostaglandins in normal physiologic settings, it has been hypothesized that the maternal contribution of prostaglandins in the placenta allows the prostaglandindeficient embryos to develop normally (Reese et al. 2000 (Reese et al. , 2001 . Consistent with this notion, mammalian blastocysts produce high levels of PGE 2 and PGF 2␣ (Dey et al. 1980; Davis et al. 1983) , and murine blastocysts cultured outside of the uterus do not survive in the presence of COX inhibitors (H. Wang and S.K. Dey, pers. comm.) . Therefore, the functional role of prostaglandins and the signaling cascades they regulate in early development have been virtually unknown.
By using the externally developing zebrafish embryos as a model system, we circumvented the maternal interference, allowing us to study the functional role for endogenous prostaglandins. Our data conclusively demonstrate the conservation of the PGE 2 signaling pathway in vertebrates. Previous studies in zebrafish demonstrated that COX-1-derived prostaglandins may be important for early development (Grosser et al. 2002; Cha et al. 2005 ).
Here we show that prostaglandins during gastrulation are produced mainly by COX-1, since COX-2 expression does not take place until after the end of gastrulation. Furthermore, we demonstrate that expression of Ptges colocalizes with that of COX-1 and the COX-1-Ptges pathway governs the production of PGE 2 during gastrulation. Previous work showed that COX-1 is coupled to cytosolic PGE 2 synthase (cPGES), while COX-2 is colocalized with microsomal PGE 2 synthase (Ptges) (Takeda et al. 2004 ) in gastrointestinal hamartomas. In zebrafish, Ptges colocalizes with COX-1 during gastrulation, but is coexpressed with both COX isoforms during somitogenesis in the posterior intermediate mesoderm and anterior neuroectoderm (Y.I. Cha, L. Solnica-Krezel, and R.N. DuBois, unpubl.), suggesting that Ptges may be the predominant source of PGE 2 during embryogenesis. Consistently, when we injected antisense morpholino oligonucleotides targeting cytosolic PGE 2 synthase in zebrafish, we didn't observe any phenotypic changes during gastrulation or thereafter (data not shown). This finding is similar to the situation reported in mice, where inactivation of mouse Ptges reduces inflammatory responses to carrageenan, similar to the effects of NSAIDs, while the cPGES-derived PGE 2 is relatively unimportant (Trebino et al. 2003) , suggesting that Ptges may also be the dominant source of PGE 2 during inflammation. Taken together, our data suggest that the COX-1-Ptges pathway may be solely responsible for providing basal levels of PGE 2 during early development. During vertebrate gastrulation, changes in the levels of proteins that regulate cell movement can impair gastrulation in either LOF or GOF experiments (Jessen et al. 2002; Carreira-Barbosa et al. 2003; Lin et al. 2005) . Similarly, LOF or GOF experiments with EP4 receptor both result in gastrulation defects, while overexpression of ptges or treatment with PGE 2 does not produce a noticeable change in gastrulation phenotype. In addition, the phosphorylation status of Akt in wild-type embryos treated with PGE 2 remains unaltered (Fig. 6F) . These data suggest that PGE 2 plays an essential, but permissive, role during vertebrate gastrulation. It remains to be determined whether the excess EP4 receptor impairs gastrulation by increased normal signaling or functions by an antimorphic or neomorphic activity.
One of the more interesting questions that arises from this study is why does the ptges-MO cause an even stronger phenotype than the one observed in EP4 morphants? From cell culture experiments, we know that PGE 2 can exert effects that are not totally dependent on the EP4 receptor. For example, we have previously reported that PGE 2 can indirectly transactivate the peroxisome proliferator-activated receptor ␦ (PPAR␦) receptor in colorectal adenoma growth in APC min mice (Wang et al. 2004 ). Therefore, we hypothesize that during zebrafish gastrulation, loss of PGE 2 can lead to a stronger phenotype than that exhibited by EP4 morphants due to a disruption of processes independent of the EP4 pathway. In support of this, there are differences in Ptges and EP4 morphant phenotypes at 24 hpf (Figs. 2S, 3F ). However, our data convincingly demonstrate that the effects of PGE 2 on cell movement are dependent specifically on the EP4 receptor.
Another intriguing concept that arises from this study is the conserved role of the EP4-PI3K/Akt pathway in regulation of cell movement. Previous work in zebrafish demonstrated that PI3K/Akt signaling is required downstream of PDGF for proper cell shape, process formation, and movement during anterior migration of prechordal mesodermal cells (Montero et al. 2003) . However, our studies also implicate PI3K/Akt signaling in proper convergence, extension, and epiboly processes. We provide two lines of evidence that suggest PI3K/Akt lies downstream of PGE 2 during gastrulation: First, we observed decreased activation of Akt in EP4-deficient embryos. Second, loss-of-function phenotypes in Ptges-and EP4-deficient embryos share similar defects in convergence, extension, and epiboly to those of embryos treated with a PI3K inhibitor. With respect to gastrulation cell behaviors that depend on this pathway, our cell tracking data support the notion that EP4 receptor signaling uses PI3K/Akt to promote cell motility, rather than cell shape or persistence of migration. Consistently, zebrafish primordial germ cells also depend on PI3K signaling for cell motility during their migration (Dumstrei et al. 2004) , while PI3K/Akt signaling has been implicated also in cell movement and directionality during neutrophil migration (Stephens et al. 2002; Wang et al. 2002) . These observations suggest that PI3K/Akt is a key regulator of distinct properties of moving cells in various cellular contexts. Therefore, we cannot exclude the possibility that EP4 signaling may regulate other aspects of cell behavior during zebrafish gastrulation and development.
So, how does the EP4 receptor activate the PI3K/Akt pathway? As mentioned earlier, the EP4 receptor is a member of the GPCR superfamily. Previous studies in mammalian cell culture demonstrated that G␤␥ dimers transmit signals from GPCR to a variety of intracellular effectors in distinct cellular contexts (Schwindinger and Robishaw 2001) . One of the targets of G␤␥ dimers involves direct activation of PI3K by binding of specific G␤␥ dimers to both subunits of PI3K (Leopoldt et al. 1998) . Whether G␤␥ dimers can transduce EP4 signaling still remains to be seen both in mammalian settings as well as during zebrafish gastrulation. However, our perusal through the zebrafish genome revealed that the presence of multiple human G␤ and G␥ homologs and their role during zebrafish gastrulation have not yet been elucidated.
Although PGE 2 signaling has been shown to promote migration and invasive behaviors of several cancer cell lines in vitro (Sheng et al. 2001; Buchanan et al. 2003) , the cell movement behaviors and molecular pathways regulated by PGE 2 signaling in vivo are not known. Our studies provide the first evidence that PGE 2 signaling regulates cell movement in vivo by promoting cell motility during gastrulation. Understanding the detailed mechanism of PGE 2 signaling in zebrafish gastrulation may ultimately provide significant insights into how PGE 2 regulates various processes that require cell movement, including metastatic spread of cancer.
Materials and methods
Zebrafish maintenance, embryo generation, and staging AB* and TL wild-type zebrafish strains were maintained as described (Solnica-Krezel et al. 1996) . Embryos were obtained from natural spawnings and staged according to morphology as described (Kimmel et al. 1995) .
Cloning of prostaglandin E 2 receptors and synthases
An expressed sequence tag (EST) with sequence similarity to human EP2 and EP4 receptors were isolated by PCR (Advantage2; Clontech), and cloned into the pCR2.1 vector (Invitrogen) and used for antisense probe synthesis with SP6 RNA polymerase. For misexpression, the full-length cDNA was cloned into the pCS2+ vector and used for capped RNA synthesis with SP6 RNA polymerase after NotI linearization (mMESSAGE mMACHINE; Ambion). The NCBI accession numbers for EP2 and EP4 are DQ286580 and DQ202321, respectively. To obtain full-length prostaglandin E 2 synthases, we designed primers against previously isolated sequences of ptges and cpges (Pini et al. 2005) and isolated them by PCR (Advantage2; Clontech). Full-length PCR products were cloned into the pCR2.1 vector (Invitrogen) and used for antisense probe synthesis with SP6 RNA polymerase.
In situ hybridization
Antisense probes for zebrafish cox1 and cox2 were synthesized as described (Grosser et al. 2002) . Antisense RNA probes were synthesized from cDNAs encoding six3b (Kobayashi et al. 1998) , ntl (Schulte-Merker et al. 1992) , and pax2.1 (Krauss et al. 1991b ). Whole-mount in situ hybridization was performed ac-cording to Marlow et al. (2002) . Embryos were analyzed on a Zeiss Axioplot, and images were captured with the Nikon Coolpix 4500. Each in situ experiment was done at least twice, using ∼20 embryos.
MO design and MO/RNA injections
MO design and MO/RNA injections were performed at the one-cell stage as described . MOs were designed to the predicted start codon (MO1) and first exon-intron boundary (MO2) of ptges (underline indicates the predicted start codon): ptges-MO1 (5Ј-TCAGCAAAAAGTTACACTCT CTCAT-3Ј) and ptges-MO2 (5Ј-GTTTTGTGCTCTTACCTCC TACAGC-3Ј). For EP receptors, we designed two MOs against the 5Ј-UTR (MO1) and the predicted start codon (MO2): ep2-MO1 (5Ј-GATGTTGGCATGTTTGAGAGCATGC-3Ј), ep2-MO2 (5Ј-ACTGTCAATACAGGTCCCATTTTC-3Ј), ep4-MO1 (5ЈCG CGCTGGAGGTCTGGAGATCGCGC-3Ј), ep4-MO2 (5Ј-CAC-GGTGGGCTCCATGCTGCTGCTG-3Ј), and ep4-MOc (5Ј-CAt GGTGGcgTgCATGCTaCTGCTG-3Ј; lowercase letters denote mutated sites). All MOs were obtained from Gene Tools, LLC. Zebrafish ep4 sense-capped RNA was synthesized using mMessage Machine (Ambion) after template linearization with enzyme. For phenotype rescue and phenocopy experiments, 80 pg of ep4 RNA and 2 ng of ep4-MO2 per embryo were used.
Prostaglandin rescue experiments
For prostaglandin supplementation experiments, we used commercially available prostaglandins (Cayman), PGE 2 , PGF 2␣ , and PGI 2 . We supplemented Ptges-deficient embryos with 5 µM PGs in 1% DMSO egg media at the beginning of the epiboly process as previously described (Cha et al. 2005) .
Nomarski time-lapse analysis
Images of lateral gastrula mesodermal cells at mid-gastrulation (80% epiboly) were carried out as described previously (Myers et al. 2002a) . Cell movement measurement data obtained in Object-Image (NIH image) were exported to Excel (Microsoft), where cell migration speed, path, direction, turning angle, and LWRs were determined. The movement direction of lateral mesodermal cells was determined at 1-min intervals.
Inhibitor treatment
To block PI3K and PDGF activity, we used LY294002 (Calbiochem), a specific inhibitor of PI3K activity (Vlahos et al. 1994) . Embryos were usually treated from 30% epiboly to the YPC stage in 10 or 30 µM LY294002 to monitor the phenotypes.
Western blot analysis
Embryos were injected with ptges-MO, ep2-MO2, or ep4-MO2, or treated with LY. Endogenous levels of Akt and ERK activation were measured. Embryos were injected with a 2-ng dose of ptges-MO, ep2-MO2, ep4-MO2 wild type at the one-cell stage, or treated with PGE 2 starting at the 30% epiboly stage. Embryos were then collected between the 80% and 90% epiboly stage, dechorionated manually, and homogenized in 50 mM HEPES (pH 7.5), 150 mM NaCl, 1% Triton X-100. Equal amounts of samples were separated by SDS-PAGE and transferred to polyvinylidene difluoride membranes. The membranes were blocked in TTBS (Tris-buffered saline with 0.1% Tween 20) containing either 5% dry milk or BSA. Primary antibody incubations were performed in TTBS with either 5% dry milk or BSA overnight at 4°C. After washing, the membranes were incubated with the appropriate secondary peroxidase-conjugated antibody for 1 h in TTBS with either 5% dry milk or BSA. Immunoreactive proteins were visualized using the enhanced chemiluminescence system from Amersham Biosciences. Antibodies to Akt, Erk, phospho-Akt, and phospho-Erk were obtained from Cell Signaling.
